Soliton (SOLY) Reports In-Line Q3 EPS

Soliton (NASDAQ: SOLY) reported Q3 EPS of ($0.17), in-line with the analyst estimate of ($0.17).

Third Quarter Company Highlights:

• Appointed aesthetic veteran Brad Hauser as President and CEO in preparation for commercial product launch
• Added cosmetic dermatology expert Dr. Michael Kaminer and Niquette Hunt, a medical device and aesthetics industries entrepreneur, to Board of Directors
• Presented pivotal cellulite data at the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting
• Presented pivotal cellulite and tattoo removal data in two separate presentations at the Masters in Aesthetics Symposium
• Met significant R&D and operations milestones to progress towards launch readiness
• Enhanced our commercial team with key strategic marketing partners and a new distributor

Brad Hauser, Soliton's newly appointed President and CEO, commented, "I am truly excited to be joining the Soliton team at such a pivotal time for the Company. During the third quarter, we executed on several key milestones which we believe position us optimally for our planned commercial launch of the RAP device for both tattoo removal and cellulite reduction, pending FDA clearance on the latter. We are extremely proud of our progress with our new, innovative handpiece design and our efforts to successfully transition into manufacturing, recently completing tooling production for the RAP device. Through key partnerships with two excellent marketing agencies and a new distributor, that specializes on high volume tattoo removal practices, we have bolstered our commercial strategy to enhance future customer engagement and receptivity. With these achievements and our current balance sheet, we believe we are well-funded and well-prepared to execute a successful initial launch in the first half of 2021."

For earnings history and earnings-related data on Soliton (SOLY) click here.

You May Also Be Interested In

• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c